Merck & Co., Inc. (NYSE:MRK)

CAPS Rating: 4 out of 5

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

Recs

0
Player Avatar bordereiver (< 20) Submitted: 8/20/2011 10:03:10 AM : Outperform Start Price: $30.60 MRK Score: +7.99

People looking for solid defensive moves with good dividend.

Featured Broker Partners


Advertisement